Direct identification of neoantigen-specific TCRs from tumor specimens by high-throughput single-cell sequencing
出版年份 2021 全文链接
标题
Direct identification of neoantigen-specific TCRs from tumor specimens by high-throughput single-cell sequencing
作者
关键词
-
出版物
Journal for ImmunoTherapy of Cancer
Volume 9, Issue 7, Pages e002595
出版商
BMJ
发表日期
2021-07-29
DOI
10.1136/jitc-2021-002595
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CD39 identifies the CD4+ tumor-specific T cell population in human cancer
- (2020) Kim E Kortekaas et al. Cancer Immunology Research
- T cell antigen discovery via signaling and antigen-presenting bifunctional receptors
- (2019) Alok V. Joglekar et al. NATURE METHODS
- Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers
- (2019) Maria R. Parkhurst et al. Cancer Discovery
- T-Scan: A Genome-wide Method for the Systematic Discovery of T Cell Epitopes
- (2019) Tomasz Kula et al. CELL
- Sensitive Detection and Analysis of Neoantigen-Specific T Cell Populations from Tumors and Blood
- (2019) Songming Peng et al. Cell Reports
- Single-Cell Transcriptome Analysis Reveals Gene Signatures Associated with T-cell Persistence Following Adoptive Cell Therapy
- (2019) Yong-Chen Lu et al. Cancer Immunology Research
- Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytes
- (2019) Alena Gros et al. JOURNAL OF CLINICAL INVESTIGATION
- Developing neoantigen-targeted T cell–based treatments for solid tumors
- (2019) Tori N. Yamamoto et al. NATURE MEDICINE
- Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4
- (2019) Jitske van den Bulk et al. Genome Medicine
- Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes
- (2018) Marvin H. Gee et al. CELL
- An Efficient Single-Cell RNA-Seq Approach to Identify Neoantigen-Specific T Cell Receptors
- (2018) Yong-Chen Lu et al. MOLECULAR THERAPY
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
- (2018) Thomas Duhen et al. Nature Communications
- Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade
- (2018) Rikke B. Holmgaard et al. Journal for ImmunoTherapy of Cancer
- Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
- (2018) Yannick Simoni et al. NATURE
- Cancer Neoantigens
- (2018) Ton N. Schumacher et al. Annual Review of Immunology
- High-throughput determination of the antigen specificities of T cell receptors in single cells
- (2018) Shu-Qi Zhang et al. NATURE BIOTECHNOLOGY
- Antigen discovery and specification of immunodominance hierarchies for MHCII-restricted epitopes
- (2018) Daniel B. Graham et al. NATURE MEDICINE
- Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers
- (2018) Wouter Scheper et al. NATURE MEDICINE
- Preclinical assessment of galunisertib (LY2157299 monohydrate), a first-in-class transforming growth factor-β receptor type I inhibitor
- (2017) Jonathan M. Yingling et al. Oncotarget
- Tumor-infiltrating lymphocytes (TILs) from patients with glioma
- (2017) Zhenjiang Liu et al. OncoImmunology
- Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
- (2016) Alena Gros et al. NATURE MEDICINE
- T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
- (2016) Eric Tran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer immunotherapy targeting neoantigens
- (2016) Yong-Chen Lu et al. SEMINARS IN IMMUNOLOGY
- Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor
- (2016) A. Pasetto et al. Cancer Immunology Research
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- Immunogenicity of somatic mutations in human gastrointestinal cancers
- (2015) E. Tran et al. SCIENCE
- A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
- (2015) B. M. Carreno et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Akt Inhibition Enhances Expansion of Potent Tumor-Specific Lymphocytes with Memory Cell Characteristics
- (2014) J. G. Crompton et al. CANCER RESEARCH
- Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions
- (2014) Y.-C. Lu et al. CLINICAL CANCER RESEARCH
- PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
- (2014) Alena Gros et al. JOURNAL OF CLINICAL INVESTIGATION
- Linking T-cell receptor sequence to functional phenotype at the single-cell level
- (2014) Arnold Han et al. NATURE BIOTECHNOLOGY
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
- (2014) E. Tran et al. SCIENCE
- Mutated PPP1R3B Is Recognized by T Cells Used To Treat a Melanoma Patient Who Experienced a Durable Complete Tumor Regression
- (2013) Y.-C. Lu et al. JOURNAL OF IMMUNOLOGY
- Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
- (2013) Paul F Robbins et al. NATURE MEDICINE
- Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy
- (2010) Gavin M Bendle et al. NATURE MEDICINE
- IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
- (2008) C. S. Hinrichs et al. BLOOD
- Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression
- (2008) Jennifer A. Wargo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started